India to Australia: Theophylline Export Trade Route

The India to Australia Theophylline corridor is one of India's established pharmaceutical export routes, with 18 shipments documented worth a combined $83.8K USD. The route is dominated by ADCOCK INGRAM LIMITED, which alone accounts for roughly 59% of all export value, reflecting the consolidated nature of India's theophylline manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $4.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with theophylline's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 24.9%, placing it at rank #19 among India's top theophylline export destinations globally.

On the import side, key buyers of Indian theophylline in Australia include INOVA PHARMACEUTICALS AUSTRALIA, INOVA PHARMACEUTICALS (AUSTRALIA),. , INOVA PHARMACEUTICALS (AUSTRALIA), and 5 others. INOVA PHARMACEUTICALS AUSTRALIA is the single largest importer with 3 shipments valued at $40.9K USD.

India's theophylline exports to Australia are driven primarily by a handful of large-scale manufacturers. ADCOCK INGRAM LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ADCOCK INGRAM LIMITED, ADCOCK INGRAM LIMITED , TULSI MEDICAL & GENERAL STORES — together account for 100% of total trade value on this route. The average shipment value of $4.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as nuelin sr 300mg tablets theophylline anhydrous 300mg guar gum ih 10 5mg tablets 13720x100s and nuelin sr-300mg tablets theophylline an, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, INOVA PHARMACEUTICALS AUSTRALIA is the largest importer with 3 shipments worth $40.9K USD — representing 49% of all theophylline imports from India on this route. A total of 8 buyers are active on this corridor.